Institutional Conflicts of Interest in Human Health Research – a Scoping Review

Abstract Background Conflict of interests (CoIs) can influence decision making in health research, raising concerns about transparency and integrity. Institutional CoIs (iCoIs) can arise for individuals and institutions alike when holding any interest affects the research process or its outcome. While progress has been made in research on individual CoIs, iCoIs remain largely unexplored. Objectives This scoping review aims to understand how iCoIs have been studied and discussed in the literature on human health research, and highlight gaps in the literature. Methods We registered a protocol of the review before commencing a systematic search in three databases in July 2024. We considered many publications types addressing iCoIs within healthcare organisations (e.g., hospitals and medical schools) published in English or German. Abstracts, policy descriptions, and papers focusing solely on review boards were excluded. Two reviewers screened abstracts, full texts, and extracted data. Results A total of 49 reports were included in the analysis. The majority stemmed from the United States and study types diverse (mainly empirical and conceptual work). iCoIs were predominantly discussed in relation to universities (57%), hospitals, medical schools, and research institutes. Involved industries included pharmaceutical companies (57%), biomedical, and medical device companies (20% each). Most studies (59%) focused on financial iCoIs only. Key concerns about iCoIs included distortion of research, threats to research integrity, or downplaying or neglecting risks. Conclusions Included publications focus primarily on financial interests related to universities, hospitals, and medical schools. While a multitude of potential threats to research integrity are identified, non-financial interests are not fully researched. There is need for empirical research of all types of iCoIs beyond case studies, and for evaluating current iCoI management strategies, particularly in other countries than the US. Key messages • Institutional conflicts of interest are largely unexplored. This scoping review shows that most publications focus on the US context and financial interests. • Detailed empirical studies are missing.

Institutions

Publication Details

Journal
European Journal of Public Health
Published
2025-10-01
DOI
https://doi.org/10.1093/eurpub/ckaf161.1359
Primary Topic
Pharmaceutical industry and healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Institutional Conflicts of Interest in Human Health Research – a Scoping Review

European Journal of Public Health
Pharmaceutical industry and healthcare
article

Institutional Conflicts of Interest in Human Health Research – a Scoping Review

article en

Abstract

Abstract Background Conflict of interests (CoIs) can influence decision making in health research, raising concerns about transparency and integrity. Institutional CoIs (iCoIs) can arise for individuals and institutions alike when holding any interest affects the research process or its outcome. While progress has been made in research on individual CoIs, iCoIs remain largely unexplored. Objectives This scoping review aims to understand how iCoIs have been studied and discussed in the literature on human health research, and highlight gaps in the literature. Methods We registered a protocol of the review before commencing a systematic search in three databases in July 2024. We considered many publications types addressing iCoIs within healthcare organisations (e.g., hospitals and medical schools) published in English or German. Abstracts, policy descriptions, and papers focusing solely on review boards were excluded. Two reviewers screened abstracts, full texts, and extracted data. Results A total of 49 reports were included in the analysis. The majority stemmed from the United States and study types diverse (mainly empirical and conceptual work). iCoIs were predominantly discussed in relation to universities (57%), hospitals, medical schools, and research institutes. Involved industries included pharmaceutical companies (57%), biomedical, and medical device companies (20% each). Most studies (59%) focused on financial iCoIs only. Key concerns about iCoIs included distortion of research, threats to research integrity, or downplaying or neglecting risks. Conclusions Included publications focus primarily on financial interests related to universities, hospitals, and medical schools. While a multitude of potential threats to research integrity are identified, non-financial interests are not fully researched. There is need for empirical research of all types of iCoIs beyond case studies, and for evaluating current iCoI management strategies, particularly in other countries than the US. Key messages • Institutional conflicts of interest are largely unexplored. This scoping review shows that most publications focus on the US context and financial interests. • Detailed empirical studies are missing.

European Journal of Public HealthVol. 35(Supplement_4)
Witten/Herdecke University (DE), Medizinische Hochschule Brandenburg Theodor Fontane (DE), American University of Beirut (LB)
Peace, Justice and strong institutions
Openalex Percentile: Top 38%
Pharmaceutical industry and healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.